In patients with type 2 diabetes the presence of Hashimoto’s thyroiditis reduces the beneficial effect of dipeptidyl peptidase–4 inhibitor on plasma glucose control von Watanabe, Takuya, Temma, Yuichi, Okada, Junichi, Yamada, Eijiro, Saito, Tsugumichi, Osaki, Aya, Shimda, Yoko, Matsumoto, Shunichi, Horiguchi, Kazuhiko, Ishida, Emi, Kondo, Yuri, Okada, Kazuya, Takamizawa, Tetsuya, Nakajima, Yasuyo, Ozawa, Atsushi, Okada, Shuichi, Horigome, Mitsuaki, Yamada, Masanobu

Volltext

In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control von Takuya Watanabe, Yuichi Temma, Junichi Okada, Eijiro Yamada, Tsugumichi Saito, Aya Osaki, Yoko Shimda, Shunichi Matsumoto, Kazuhiko Horiguchi, Emi Ishida, Yuri Kondo, Kazuya Okada, Tetsuya Takamizawa, Yasuyo Nakajima, Atsushi Ozawa, Shuichi Okada, Mitsuaki Horigome, Masanobu Yamada

Volltext

In patients with type 2 diabetes the presence of Hashimoto’s thyroiditis reduces the beneficial effect of dipeptidyl peptidase–4 inhibitor on plasma glucose control von Watanabe, Takuya, Temma, Yuichi, Okada, Junichi, Yamada, Eijiro, Saito, Tsugumichi, Osaki, Aya, Shimda, Yoko, Matsumoto, Shunichi, Horiguchi, Kazuhiko, Ishida, Emi, Kondo, Yuri, Okada, Kazuya, Takamizawa, Tetsuya, Nakajima, Yasuyo, Ozawa, Atsushi, Okada, Shuichi, Horigome, Mitsuaki, Yamada, Masanobu

Volltext